We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
-$1.13B
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,446
Increased
2,646
Reduced
3,048
Closed
1,267

Sector Composition

Rank Sector Weight
1 Technology 7.41%
2 Consumer Discretionary 6.04%
3 Financials 5.89%
4 Industrials 4.61%
5 Healthcare 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NERV icon
6651
Minerva Neurosciences
NERV
$212M
$110K ﹤0.01%
+1,690
New +$131K
GNCA
6652
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$110K ﹤0.01%
+2,250
New +$87.9K
AVAL icon
6653
Grupo Aval
AVAL
$6.38B
$109K ﹤0.01%
+13,371
New +$108K
GLAD icon
6654
Gladstone Capital
GLAD
$447M
$109K ﹤0.01%
+5,733
New +$107K
NVAX icon
6655
Novavax
NVAX
$1.31B
$109K ﹤0.01%
4,279
+2,820
+193% +$77.5K
PZN
6656
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$109K ﹤0.01%
11,107
-3,551
-24% -$36K
OMED
6657
CALL
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$109K ﹤0.01%
11,800
-5,600
-32% -$49.2K
ARCO icon
6658
PUT
Arcos Dorados Holdings
ARCO
$1.71B
$108K ﹤0.01%
+13,773
New +$85K
CERS icon
6659
PUT
Cerus
CERS
$570M
$108K ﹤0.01%
24,300
-13,100
-35% -$55.5K
HDSN
6660
Hudson Technologies
HDSN
$239M
$108K ﹤0.01%
16,376
-5,189
-24% -$37.8K
VATE icon
6661
PUT
INNOVATE Corp
VATE
$104M
$108K ﹤0.01%
+1,740
New +$108K
HIVE
6662
DELISTED
Aerohive Networks
HIVE
$108K ﹤0.01%
+25,563
New +$128K
EPE
6663
PUT
DELISTED
EP Energy Corporation
EPE
$108K ﹤0.01%
22,700
-11,500
-34% -$58.9K
TESO
6664
DELISTED
Tesco Corp
TESO
$108K ﹤0.01%
+13,434
New +$114K
HLIT icon
6665
CALL
Harmonic Inc
HLIT
$1.5B
$107K ﹤0.01%
+18,000
New +$98.7K
NSLR
6666
PUT
Neostellar Capital Corp
NSLR
$282M
$107K ﹤0.01%
28,472
-4,288
-13% -$18.7K
ATHX
6667
DELISTED
Athersys, Inc. Common Stock
ATHX
$107K ﹤0.01%
2,498
+1,909
+324% +$61K
JE
6668
DELISTED
Just Energy Group Inc
JE
$107K ﹤0.01%
516
-1,151
-69% -$221K
FRSH
6669
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$107K ﹤0.01%
+22,534
New +$97.4K
SNAK
6670
CALL
DELISTED
Inventure Foods, Inc.
SNAK
$107K ﹤0.01%
+24,100
New +$145K
COLL icon
6671
CALL
Collegium Pharmaceutical
COLL
$907M
$105K ﹤0.01%
+10,400
New +$155K
HIO
6672
Western Asset High Income Opportunity Fund
HIO
$339M
$105K ﹤0.01%
+20,833
New +$106K
LCTX icon
6673
Lineage Cell Therapeutics
LCTX
$268M
$105K ﹤0.01%
34,820
-27,420
-44% -$77.9K
NPTN
6674
CALL
DELISTED
NEOPHOTONICS CORP
NPTN
$105K ﹤0.01%
+11,700
New +$122K
CGI
6675
PUT
DELISTED
Celadon Group Inc
CGI
$105K ﹤0.01%
+16,000
New +$131K

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors's Q1 2017 filing shows 1,446 new, 2,646 increased, 3,048 reduced and 1,267 closed positions. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M. The largest sale was Alphabet (Google) Class A, an estimated $482M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 5.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,446 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.